These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20513005)

  • 21. [Efficacy of lisinopril and nebivolol therapy of portal hypertension and kidney dysfunction in patients with liver cirrhosis].
    Fedulenkova LV; Drozdov VN; Mikheeva OM; Petrakov AV
    Eksp Klin Gastroenterol; 2008; (5):37-41. PubMed ID: 19145915
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacological treatment of the portal hypertension].
    Castañeda Romero B
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():64-5. PubMed ID: 17471863
    [No Abstract]   [Full Text] [Related]  

  • 23. [Medical therapy of portal hypertension due to liver cirrhosis].
    Cerini R; Sperandeo M; Varriale A; De Rosa ML; Cacciatore L
    Recenti Prog Med; 1991 Feb; 82(2):91-9. PubMed ID: 2034876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carvedilol: the β-blocker of choice for portal hypertension?
    Bosch J
    Gut; 2013 Nov; 62(11):1529-30. PubMed ID: 23355548
    [No Abstract]   [Full Text] [Related]  

  • 25. Does losartan work after all?
    Blendis LM; Wong F
    Am J Gastroenterol; 2003 Jun; 98(6):1222-4. PubMed ID: 12818261
    [No Abstract]   [Full Text] [Related]  

  • 26. [Carvedilol].
    Antepohl W; Herzig S; Böhm M
    Dtsch Med Wochenschr; 1997 Jun; 122(25-26):833-4. PubMed ID: 9244672
    [No Abstract]   [Full Text] [Related]  

  • 27. How safe is carvedilol in NIDDM patients with hypertension?
    Choudhury D; Misra A
    Natl Med J India; 1998; 11(3):130-1. PubMed ID: 9707705
    [No Abstract]   [Full Text] [Related]  

  • 28. Losartan in preascitic cirrhosis.
    Castaño G; Viudez P; Sookoian S
    Am J Gastroenterol; 2004 Nov; 99(11):2282-3. PubMed ID: 15555016
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical experience with carvedilol.
    Moser M
    J Hum Hypertens; 1993 Feb; 7 Suppl 1():S16-20. PubMed ID: 8098064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic management of portal hypertension.
    Berzigotti A; Bosch J
    Clin Liver Dis; 2014 May; 18(2):303-17. PubMed ID: 24679496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of salt intake on the antihypertensive effect of carvedilol.
    Ruilope LM; Lahera V
    J Hypertens Suppl; 1993 Jun; 11(4):S17-9. PubMed ID: 8104238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Does carvedilol minimize the requirements for laser photocoagulation in diabetic retinopathy?].
    Auyanet I; Rodríguez LJ; Esparza N; Cabrera F; Rossique P; Suria S; Cardona P; Checa MD
    Nefrologia; 2010; 30(4):473-4. PubMed ID: 20651891
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experimental pharmaceutical therapy of sinusoidal portal hypertension].
    Tarantino G; Mascolo G; Vitaglione R; De Rosa G
    Boll Chim Farm; 1984 Jan; 123(1):6S-15S. PubMed ID: 6721936
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical efficacy of carvedilol in severe hypertension.
    Ogihara T; Yoshinaga K; Kamahara Y; Ikeda M; Goto Y; Arakawa K; Iimura I; Ishii M; Kokubu T; Takeda T
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S69-72. PubMed ID: 1721983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
    Deetjen A; Heidland A; Pangerl A; Meyer-Sabellek W; Schaefer RM
    Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of a nonselective beta-blocker, nadolol, in the treatment of portal hypertension in cirrhotics.
    Gatta A; Sacerdoti D; Merkel C; Rossoni R; Finucci G; Bolognesi M; Zuin R
    Int J Clin Pharmacol Res; 1985; 5(6):413-8. PubMed ID: 4093219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Refining the Logic of Antihypertensive Therapy: An International Symposium on Carvedilol. Paris, France, October 19, 1990.
    J Hum Hypertens; 1993 Feb; 7 Suppl 1():S1-67. PubMed ID: 8098063
    [No Abstract]   [Full Text] [Related]  

  • 38. [Carvedilol (dilatrend) treatment in cardiac failure].
    Drapkina OM; klimenkov AV; Ivashkin VT
    Ter Arkh; 2004; 76(12):88-90. PubMed ID: 15724937
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparative study of carvedilol, slow-release nifedipine, and atenolol in the management of essential hypertension.
    Hall S; Prescott RI; Hallman RJ; Dixon S; Harvey RE; Ball SG
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S35-8. PubMed ID: 1721977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carvedilol.
    Frishman WH
    N Engl J Med; 1998 Dec; 339(24):1759-65. PubMed ID: 9845712
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.